Oxford Pharm Gp Share Discussion Threads

[blueball] 27/1/2017 12:24

Worth a bet.

[nick rubens] 27/1/2017 11:58

If they can secure a big pharma customer for their product, then this will soar. The market thinks the company and it's product is a waste of time, so values it at cash.

If the market is wrong, then this is a serious buy opportunity having raised £20m, not long ago at 10p placing subscription.

I'm holding a few for that reason.

[blue sky territory] 27/1/2017 11:24

What do you think temm?

Hotting up?

[barnetpeter] 27/1/2017 10:59

Yes it does and a steady increase in price and full ask.

The bear case is that the products are of limited value.

The bull case is that they have 22 million in cash....enough to produce 700K in interest per year to cover a lot of general costs.


I dont know the value but we are 80% down from the July 15 highs and the risk is now limited unless they are throwing cash out the window.

[theslimguy] 27/1/2017 09:49

Chart looks very tasty

[fillipe] 27/1/2017 09:47

A nice uptick- about what I anticipated, just for now. It all adds weight to a steady upward move in the share price going forward and I'm very happy to hold for that more to come.

f

[blue sky territory] 27/1/2017 09:09

Not I.

4p more like, on a good day.

[burbelly] 27/1/2017 09:04

Anyone waiting for larma's 1.2p?

[the great unwashed] 27/1/2017 08:54

I'm with you on that fillipe.

[fillipe] 26/1/2017 20:08

Looking for 3p short term.

hxxps://masterinvestor.co.uk/trading/oxford-pharmascience-break-of-50-day-line-could-lead-towards-3p/?utm_source=Daily+Bulletin&utm_campaign=2fc334e724-MI_MR_20170126&utm_medium=email&utm_term=0_25eff0bb7f-2fc334e724-34922033

Very easy to see that 3p coming here with ease, and as ever, suchlike has a habit of overshooting once the momentum kicks in.

Seems case here of the need for "being in to win".

f

[donald trumpton] 23/1/2017 11:37

Here we go lads..

[barnetpeter] 23/1/2017 11:14

More buying today and a good entry point I think.

The bears have always been right on this so far and encouraged me to sell this at a much higher price.....however


As at 31 December 2016, the Company had net cash of circa GBP21.9 million and remains well funded to pursue its strategy.


That is a lot of cash and I am sure other companies may be looking at this. It gives them a lot of flexibility. Their current business may be rubbish indeed but the risk at this price is not what it was at 10p or 8p or whatever.

[sleveen] 18/1/2017 18:27

What a pile of fluff that RNS was.

"Specifically, by comparison with generic NSAIDs, OXPzero(TM) Ibuprofen and OXPzero(TM) Naproxen are milder in the GI tract, delivering major reduction in severe GI mucosal damage, significantly mask the bitter taste/burn associated with NSAIDs, and deliver an attractive pharmacokinetic profile with adaptable drug release properties"


NSAID are not nice drugs and their adverse effects are mainly (circa 90%)due to systemic effects rather than local GI irritation.
They reduce renal perfusion, are GI toxic and and anti-prostacyclin ie can induce throboembolic events. This is due to inhibition of the COX 1 pathway.

With NSAIDs you prescribe low and go slow, particularly in the elderly.

Look like the release mechanism might improve bioavaialability [my conclusion] ...yawn.

Phase 1 clinical trials blah de blah de blah

That said they do reduce pain quite well though it doesn't take a fancy release technology to do that.

timbo003 your opinion is correct

IMVHO.

[luckymouse] 17/1/2017 18:29

Well I certainly respect your technical knowledge timbo - there of course are many different valid sciences & dark arts - in my field this is approaching an area of interest, which if combined with say the right type of news catalyst may well bring the hoards. Rising accumulation conditions aren't quite right yet so keeping an eye. Have a good evening. ATB LM

[timbo003] 17/1/2017 18:03

>>>>lucky Mouse

I have absolutely no idea where the share price is going in the short term, I just know that the technology (if you can call it that) is fundamentally flawed. I have been saying this for the last 3-4 years, all the way from around 3p, up to 12p and back down again to sub 2p

[luckymouse] 17/1/2017 17:33

Extremely shouty style timbo? Both +ve & -ve. If that bowl breaks 2 its not be the place to be short mind...there is a historic accumulation zone somewhere around here - prob 1.3-1.8 area - any good news in or above that and traders will probably pile in regardless

[blue sky territory] 17/1/2017 16:43

Quite reasonable.

[10p here we come] 17/1/2017 16:03

I'm a Buyer today.

..looking for 4p.

[typhoon] 17/1/2017 10:08

I agree Timbo I am invested here but feel like these guys have their head in the sand

[timbo003] 17/1/2017 07:43

Here's the link to the proposed studies:


Grasping at straws still I see

Why don't they just give up on this stupid idea and either concentrate on their original core business of taste masking, or return cash to shareholders?

Why on earth don't they realise that they cannot have their cake and eat it.

Investors should not be seduced by the cash in the bank, as their approach to what they are trying to achieve is totally futile.

[carbon man] 16/1/2017 16:00

Plenty of Cash in this company according to Balance Sheet. Unless my research is wildly out, I feel that I am happy to buy at these levels. Please let me know if I have missed something.

Thanks.

[barnetpeter] 10/1/2017 15:09

Oxford Pharmascience remains well-funded to complete this next stage of work on clinical development and the regulatory pathway for its OXPzero(TM) products, as well as the development work on atorvastatin, with cash balances as at 31 October 2016 of circa GBP22.6 million.


If the company has got something.....anything.....then its valued at roughly zero.


This has been a real dawg.....but we have had big spikes before and I think news is close.

[bumpa33] 09/1/2017 20:18

Singers were looking for stock to fill that order late Friday...

[fillipe] 09/1/2017 19:42

I've long thought that with all their £££; funds + know-how, it's only a matter of time before something significant occurs here - and more particularly so, given the shareholder base who are unlikely to leave this one just sitting there and treading water, going nowhere.

Changes afoot, I feel.

f

[nimrod22] 09/1/2017 18:05

Something going on. Obviously somebody knows something to buy £40,000 worth at 1611 hours